Cantor raises target for Merck & Co. stock to USD 145

Published on 10/12/2026 at 12:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Merck reported USD 16.61 billion in second-quarter sales. Merck & Co. stock costs EUR 130.20 on October 12, 2026 ahead of October 29 results.

Key points in brief

Cantor Fitzgerald raised its Merck price target from USD 120.00 to USD 145.00 on October 8, 2026, while keeping a Neutral rating.
Merck reported USD 16.61 billion in sales for the second quarter of 2026.
Merck & Co. stock was trading at EUR 130.20 at Lang & Schwarz on October 12, 2026.
Merck scheduled its third-quarter 2026 earnings call for October 29, 2026.

Aquarellbild eines modernen Forschungscampus mit Teich und Glasgebäuden — Aquarellmalerei eines Forschungscampus symbolisiert Merck & Co. Inc., ISIN US58933Y1055, im US-Pharmasektor angesiedelt, Illustration mit AI erstellt.

Merck & Co. stock (ISIN US58933Y1055) was trading at EUR 130.20 at Lang & Schwarz on October 12, 2026 at 12:13 p.m. CEST. On October 8, 2026, Cantor Fitzgerald analyst Carter Gould raised the Merck price target from USD 120.00 to USD 145.00 while keeping a Neutral rating, as Markets Insider reported.

Three dated portfolio signals

Merck reported USD 65.0 billion in full-year 2025 sales on February 3, 2026, according to Merck & Co. The company then reported USD 16.3 billion in first-quarter 2026 sales on April 30, 2026, also on its investor-relations page. The latest analyst action came on October 8, 2026, when Cantor Fitzgerald lifted its target by USD 25.00, a 20.83 percent increase from USD 120.00.

What does the target change imply?

The revised USD 145.00 target puts the analyst view above the current euro reference price, but the currencies are different and no direct upside calculation is appropriate. The more useful signal is the size of the revision: USD 25.00, or 20.83 percent, while the Neutral rating stayed unchanged.

Upcoming dates set the next test

Merck listed an investor event at ESMO 2026 for October 26, 2026 and a third-quarter 2026 sales and earnings conference call for October 29, 2026, according to Merck & Co. The October 29 call is the next scheduled reporting date and will test whether the business can extend the USD 16.61 billion sales base reported for the second quarter of 2026.

Merck stock price in Germany

The Lang & Schwarz quote stood at EUR 130.20 on October 12, 2026 at 12:13 p.m. CEST. On the NYSE, Merck was last at USD 145.60 on October 9, 2026 at 4:02 p.m. EDT, with a 52-week range of USD 82.01 to USD 156.92.

The further course of trading is shown by the continuously updated real-time quote of Merck & Co stock.